Physician profile
Fagunkumar Modi
NPI 1619117421
$10,571.33
in general payments reported to CMS, 2019-2025
30 companies · $761 in 2025
The $761 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $278 · 2021: $538 · 2022: $642 · 2023: $7,639 · 2024: $359 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,017 · Food and Beverage: $1,755 · Travel and Lodging: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,017.38 |
| Food and Beverage | $1,754.79 |
| Travel and Lodging | $987.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,004.50 | 2023 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $1,426.12 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.96 | 2019-2024 | Ofev |
| Cook Medical LLC | $212.45 | 2025 | Blue Rhino |
| Astrazeneca Pharmaceuticals Lp | $199.14 | 2021-2025 | Tezspire |
| Grifols USA, LLC | $178.28 | 2023-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $166.57 | 2021-2024 | Glassia |
| Pulmonx Corporation | $159.77 | 2023-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Insmed, INC. | $155.97 | 2021-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $98.02 | 2019-2022 | |
| Genzyme Corporation | $91.50 | 2020-2025 | |
| Zoll Circulation INC | $51.64 | 2020 | |
| Fujifilm Healthcare Americas Corporation | $47.30 | 2024 | Fujifilm |
| Nuwellis, INC. | $44.94 | 2019-2023 | Aquadex Smartflow Console |
| Inspire Medical Systems, INC. | $40.30 | 2023-2024 | Inspire |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $38.72 | 2022 | |
| Inogen, INC. | $36.41 | 2022 | |
| Verona Pharma, INC. | $34.97 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $34.18 | 2021-2023 | Acthar |
| Regeneron Healthcare Solutions, INC. | $34.07 | 2025 | Dupixent |
| Electromed, INC. | $34.05 | 2021-2022 | |
| Harmony Biosciences LLC | $23.71 | 2025 | |
| Vapotherm INC | $20.38 | 2022 | |
| Circassia INC. | $18.04 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.44 | 2019 | |
| Merck Sharp & Dohme LLC | $16.77 | 2023 | |
| Mylan Specialty L.P. | $15.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.05 | 2024 | Xarelto |
| Tactile Systems Technology INC | $13.07 | 2023 | Entre Plus, Flexitouch Plus |
| Teva Pharmaceuticals USA, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fagunkumar Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.